NO20074448L - Tiazolidinoner for anvendelse som inhibitorer av polo-lignende kinase (PLK) - Google Patents

Tiazolidinoner for anvendelse som inhibitorer av polo-lignende kinase (PLK)

Info

Publication number
NO20074448L
NO20074448L NO20074448A NO20074448A NO20074448L NO 20074448 L NO20074448 L NO 20074448L NO 20074448 A NO20074448 A NO 20074448A NO 20074448 A NO20074448 A NO 20074448A NO 20074448 L NO20074448 L NO 20074448L
Authority
NO
Norway
Prior art keywords
polo
kinase
inhibitors
thiazolidinones
plk
Prior art date
Application number
NO20074448A
Other languages
English (en)
Inventor
Holger Hess-Stumpp
Dirk Kosemund
Gerhard Siemeister
Olaf Prien
Knut Eis
Lars Wortmann
Damian Arnaiz
Volker Schulze
Uwe Eberspacher
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE102005005395A external-priority patent/DE102005005395A1/de
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Publication of NO20074448L publication Critical patent/NO20074448L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/12—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/14—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Oppfinnelsen vedrører tiazoli-dinonene med generell formel (I) fremstillingen og anvendelsen derav som inhibitorer av pololignende kinase (Plk) for anvendelse ved behandlingen av forskjellige sykdommer.
NO20074448A 2005-02-03 2007-08-31 Tiazolidinoner for anvendelse som inhibitorer av polo-lignende kinase (PLK) NO20074448L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE102005005395A DE102005005395A1 (de) 2005-02-03 2005-02-03 Thiazolidinone, deren Herstellung und Verwendung als Arzneimittel
US65123205P 2005-02-10 2005-02-10
PCT/EP2006/001037 WO2006082107A1 (de) 2005-02-03 2006-02-02 Thiazolidinone als inhibitoren der polo like kinase (plk) als arzneimittel

Publications (1)

Publication Number Publication Date
NO20074448L true NO20074448L (no) 2007-10-31

Family

ID=38481436

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20074448A NO20074448L (no) 2005-02-03 2007-08-31 Tiazolidinoner for anvendelse som inhibitorer av polo-lignende kinase (PLK)

Country Status (4)

Country Link
KR (1) KR20070100830A (no)
CR (1) CR9323A (no)
IL (1) IL185023A0 (no)
NO (1) NO20074448L (no)

Also Published As

Publication number Publication date
KR20070100830A (ko) 2007-10-11
CR9323A (es) 2008-02-21
IL185023A0 (en) 2007-12-03

Similar Documents

Publication Publication Date Title
NO20090628L (no) Pyridizinon derivativater
NO20080675L (no) P38-Map kinaseinhibitorer og metoder for deres anvendelse
NO20081482L (no) Delta- og epsilon-krystallformer for imatinibmesylat
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
NO20073631L (no) Metasubstituerte tiazolidinoner, fremgangsmate for fremstilling og anvendelse av disse som legemiddel
NO20082594L (no) Pyrimidinylbenzotiofenforbindelser
NO20073791L (no) Pyrazolylaminopyridinderivater anvendbare som kinaseinhibitorer
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
NO20065847L (no) Difenylimidazopyrimidiner og -imidazolaminer som inhibitorer av B-sekretase
WO2007011833A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
SG170101A1 (en) 2-pyrazinone derivatives for the treatment of disease or condition in which inhibition of neutrophil elastase activity is beneficial.
WO2008030412A3 (en) Spiropiperidine beta-secretase inhibitors for the treatment of alzheimer's disease
NO20082026L (no) Deazapuriner som er nyttige som inhibitorer for Janus-kinaser
NO20062453L (no) Tiozolidinoner, fremstilling og anvendelse derav som legemidler
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
NO20073859L (no) Pyrrolopyrazoler, potente kinaseinhibitorer
NO20056192L (no) Kapaseinhibitorer og anvendelse derav
EA200900136A1 (ru) Пирролопиримидины для фармацевтических композиций
NO20081729L (no) Nye diazaspiroalkaner og deres anvendelse for behandling av CCR8-medierte sykdommer
NO20063761L (no) Sulfonamidderivater for behandling av sykdommer
NO20084652L (no) Deazapuriner anvendelige som inhibitorer av januskinaser
NO20082496L (no) Pyrazinderivater
EP1807396A4 (en) 2-AMINOPYRIDINE COMPOUNDS USEFUL AS INHIBITORS OF BETA-SECRETASE FOR THE TREATMENT OF ALZHEIMER'S DISEASE
NO20081217L (no) Nye benzotiazolonderivater

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application